Judgment of the General Court (Ninth Chamber) of 8 September 2016.#Xellia Pharmaceuticals ApS and Alpharma, LLC, formerly Zoetis Products LLC v European Commission.#Competition — Agreements, decisions and concerted practices — Market for antidepressant medicinal products containing the active pharmaceutical ingredient citalopram — Concept of restriction of competition ‘by subject-matter’ — Potential competition — Generic medicinal products — Barriers to market entry resulting from the existence of patents — Agreement concluded between a patent holder and a generic undertaking — Duration of the Commission’s investigation — Rights of the defence — Fines — Legal certainty — Principle that penalties must have a proper legal basis.#Case T-471/13.

Judgment of the General Court (Ninth Chamber) of 8 September 2016.
Xellia Pharmaceuticals ApS and Alpharma, LLC, formerly Zoetis Products LLC v European Commission.
Competition — Agreements, decisions and concerted practices — Market for antidepressant medicinal products containing the active pharmaceutical ingredient citalopram — Concept of restriction of competition ‘by subject-matter’ — Potential competition — Generic medicinal products — Barriers to market entry resulting from the existence of patents — Agreement concluded between a patent holder and a generic undertaking — Duration of the Commission’s investigation — Rights of the defence — Fines — Legal certainty — Principle that penalties must have a proper legal basis.
Case T-471/13.

Judgment of the General Court (Ninth Chamber) of 8 September 2016.
Xellia Pharmaceuticals ApS and Alpharma, LLC, formerly Zoetis Products LLC v European Commission.
Competition — Agreements, decisions and concerted practices — Market for antidepressant medicinal products containing the active pharmaceutical ingredient citalopram — Concept of restriction of competition ‘by subject-matter’ — Potential competition — Generic medicinal products — Barriers to market entry resulting from the existence of patents — Agreement concluded between a patent holder and a generic undertaking — Duration of the Commission’s investigation — Rights of the defence — Fines — Legal certainty — Principle that penalties must have a proper legal basis.
Case T-471/13.

ECLI identifier: ECLI:EU:T:2016:460